Mindfulness for People With Incurable Cancer

May 11, 2022 updated by: Fiona Eccles, Lancaster University

A Pilot Investigation of a Mindfulness Course for People With Incurable Cancer

The study will investigate whether a mindfulness course can help people with incurable cancer who are seen by oncologists in a particular National Health Service Hospital Trust in the United Kingdom.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

It can be hard to come to terms with living with a life limiting condition such as incurable cancer and individuals are at risk of experiencing high levels of psychological distress, which can often be overlooked when the focus is on managing physical symptoms.

Mindfulness-based interventions have been shown to be helpful in reducing distress for people with cancer generally. This pilot study will use an established mindfulness programme called mindfulness for health with people with cancer which is incurable to see if this type of intervention is acceptable and useful for this group of people.

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Deemed by the oncologist to have incurable cancer
  • Patient of the University Hospitals of Morecambe Bay NHS Foundation Trust
  • Treated by an oncologist
  • Believe they are able to commit to attending most of the mindfulness course sessions
  • Oncologist assesses they are well enough to participate in the intervention

Exclusion Criteria:

  • Having any other condition or difficulty which the medical team thinks would compromise their participation in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness group
Group will receive mindfulness intervention
A course of mindfulness using the mindfulness for health programme.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability and usefulness of intervention for participants
Time Frame: Within 4 weeks of the end of the intervention
This will be a qualitative outcome, collected via semi-structured interview
Within 4 weeks of the end of the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability and usefulness of intervention for participants- 3 months
Time Frame: 3 months following completion of the intervention
This will be a qualitative outcome, collected via semi-structured interview
3 months following completion of the intervention
Change in depression anxiety and stress
Time Frame: Collected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the intervention
Using the Depression, Anxiety and Stress (DASS21) scale we will measure the change post intervention score - pre intervention score. Each subscale (depression, anxiety and stress) ranges from 0-21, with higher scores indicating higher distress. A greater decrease in scores, would mean a greater improvement in symptoms.
Collected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the intervention
Change in depression anxiety and stress-3 months
Time Frame: Collected before the intervention (up to 4 weeks before the intervention) and 3 months after the end of the intervention
Using the Depression, Anxiety and Stress (DASS21) scale we will measure the change post intervention score - pre intervention score. Each subscale (depression, anxiety and stress) ranges from 0-21, with higher scores indicating higher distress. A greater decrease in scores, would mean a greater improvement in symptoms.
Collected before the intervention (up to 4 weeks before the intervention) and 3 months after the end of the intervention
Change in mindfulness
Time Frame: Collected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the intervention
Using the Five Factor Mindfulness Questionnaire we will measure pre-post change scores.
Collected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the intervention
Change in mindfulness- 3 months
Time Frame: Collected before the intervention (up to 4 weeks before the intervention) and 3 months following the intervention
Using the Five Factor Mindfulness Questionnaire we will measure pre-post change scores
Collected before the intervention (up to 4 weeks before the intervention) and 3 months following the intervention
Change in quality of life
Time Frame: Collected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the intervention
Using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire we will measure pre-post change scores
Collected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the intervention
Change in quality of life - 3 months
Time Frame: Collected before the intervention (up to 4 weeks before the intervention) and 3 months following the intervention
Using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire we will measure pre-post change scores
Collected before the intervention (up to 4 weeks before the intervention) and 3 months following the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 19, 2018

Primary Completion (Actual)

June 30, 2019

Study Completion (Actual)

May 30, 2020

Study Registration Dates

First Submitted

February 13, 2018

First Submitted That Met QC Criteria

February 19, 2018

First Posted (Actual)

February 26, 2018

Study Record Updates

Last Update Posted (Actual)

May 12, 2022

Last Update Submitted That Met QC Criteria

May 11, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • IRASProject ID: 226702

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Mindfulness for health

3
Subscribe